Prozac Weekly

GPTKB entity

Statements (48)
Predicate Object
gptkbp:instance_of gptkb:pharmaceuticals
gptkbp:administered_by oral capsule
gptkbp:approves gptkb:FDA
gptkbp:contains fluoxetine
gptkbp:contraindication concurrent use of monoamine oxidase inhibitors
concurrent use of pimozide
concurrent use of thioridazine
allergy to fluoxetine
gptkbp:dosage_form weekly dosage
https://www.w3.org/2000/01/rdf-schema#label Prozac Weekly
gptkbp:ingredients gptkb:bulimia_nervosa
obsessive-compulsive disorder
premenstrual dysphoric disorder
panic disorder
gptkbp:interacts_with NSAIDs
MAO inhibitors
blood thinners
other antidepressants
gptkbp:is_administered_once weekly
gptkbp:is_available_in generic form
gptkbp:is_available_in_strengths 10 mg
20 mg
30 mg
60 mg
90 mg
gptkbp:is_part_of mental health treatment
selective serotonin reuptake inhibitors (SSRIs)
gptkbp:is_part_of_treatment_plan_for major depressive disorder
gptkbp:is_used_for gptkb:depression
anxiety disorders
gptkbp:manufacturer gptkb:Eli_Lilly_and_Company
gptkbp:side_effect dizziness
fatigue
nausea
insomnia
dry mouth
sexual dysfunction
gptkbp:suitable_for patients with liver disease
pregnant women without consultation
patients with a history of suicidal thoughts
patients with a history of seizures
patients taking certain medications
breastfeeding women without consultation
children under 18 without supervision
patients with bipolar disorder without mood stabilizers
gptkbp:was_approved_in gptkb:1987
gptkbp:bfsParent gptkb:Prozac
gptkbp:bfsLayer 7